We used splice blocking MOs targeting either prss59.1 or ctrb1 transcripts, selecting genes that we previously found to be either upregulated in BBS models or downregulated in Alström models, respectively (Hostelley et al., 2016). This evidence concerns the gene CTRB1 and Bardet-Biedl syndrome.